Bone and lung metastases from intracranial meningioma

Alessandra Fabi, Carmen Nuzzo, Antonello Vidiri, Mariangela Ciccarese, Alessandra Felici, Fabio Cattani, Francesco Cognetti

Research output: Contribution to journalArticle

Abstract

Fifteen percent of intracranial tumors are represented by meningiomas. Meningioma is usually a benign neoplasm; malignant histology is rare and represents about 2-10% with a 43% incidence of metastasis. The most frequent site of metastasis is the lung and rare are other sites. There are no definitive criteria to predict the recurrence or metastases of meningioma and histological grading, according to WHO criteria, is the most important predictor of malignancy. A rare case of a woman with a relapse of intracranial meningioma in the right frontal lobe who subsequently developed simultaneous bone and intrapulmonary metastases is reported. According to these sites of metastases, it is suggested that in patients with a history of relapsed meningioma, a total body CT scan should be performed in order to investigate other possible sites of disease.

Original languageEnglish
Pages (from-to)3835-3837
Number of pages3
JournalAnticancer Research
Volume26
Issue number5 B
Publication statusPublished - Sep 2006

Fingerprint

Meningioma
Neoplasm Metastasis
Bone and Bones
Lung
Recurrence
Neoplasms
Frontal Lobe
Histology
Incidence

Keywords

  • Lung and bone metastases
  • Malignant meningioma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fabi, A., Nuzzo, C., Vidiri, A., Ciccarese, M., Felici, A., Cattani, F., & Cognetti, F. (2006). Bone and lung metastases from intracranial meningioma. Anticancer Research, 26(5 B), 3835-3837.

Bone and lung metastases from intracranial meningioma. / Fabi, Alessandra; Nuzzo, Carmen; Vidiri, Antonello; Ciccarese, Mariangela; Felici, Alessandra; Cattani, Fabio; Cognetti, Francesco.

In: Anticancer Research, Vol. 26, No. 5 B, 09.2006, p. 3835-3837.

Research output: Contribution to journalArticle

Fabi, A, Nuzzo, C, Vidiri, A, Ciccarese, M, Felici, A, Cattani, F & Cognetti, F 2006, 'Bone and lung metastases from intracranial meningioma', Anticancer Research, vol. 26, no. 5 B, pp. 3835-3837.
Fabi A, Nuzzo C, Vidiri A, Ciccarese M, Felici A, Cattani F et al. Bone and lung metastases from intracranial meningioma. Anticancer Research. 2006 Sep;26(5 B):3835-3837.
Fabi, Alessandra ; Nuzzo, Carmen ; Vidiri, Antonello ; Ciccarese, Mariangela ; Felici, Alessandra ; Cattani, Fabio ; Cognetti, Francesco. / Bone and lung metastases from intracranial meningioma. In: Anticancer Research. 2006 ; Vol. 26, No. 5 B. pp. 3835-3837.
@article{324b02ad0dc14d5b9d5dc4eecc422e0a,
title = "Bone and lung metastases from intracranial meningioma",
abstract = "Fifteen percent of intracranial tumors are represented by meningiomas. Meningioma is usually a benign neoplasm; malignant histology is rare and represents about 2-10{\%} with a 43{\%} incidence of metastasis. The most frequent site of metastasis is the lung and rare are other sites. There are no definitive criteria to predict the recurrence or metastases of meningioma and histological grading, according to WHO criteria, is the most important predictor of malignancy. A rare case of a woman with a relapse of intracranial meningioma in the right frontal lobe who subsequently developed simultaneous bone and intrapulmonary metastases is reported. According to these sites of metastases, it is suggested that in patients with a history of relapsed meningioma, a total body CT scan should be performed in order to investigate other possible sites of disease.",
keywords = "Lung and bone metastases, Malignant meningioma",
author = "Alessandra Fabi and Carmen Nuzzo and Antonello Vidiri and Mariangela Ciccarese and Alessandra Felici and Fabio Cattani and Francesco Cognetti",
year = "2006",
month = "9",
language = "English",
volume = "26",
pages = "3835--3837",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 B",

}

TY - JOUR

T1 - Bone and lung metastases from intracranial meningioma

AU - Fabi, Alessandra

AU - Nuzzo, Carmen

AU - Vidiri, Antonello

AU - Ciccarese, Mariangela

AU - Felici, Alessandra

AU - Cattani, Fabio

AU - Cognetti, Francesco

PY - 2006/9

Y1 - 2006/9

N2 - Fifteen percent of intracranial tumors are represented by meningiomas. Meningioma is usually a benign neoplasm; malignant histology is rare and represents about 2-10% with a 43% incidence of metastasis. The most frequent site of metastasis is the lung and rare are other sites. There are no definitive criteria to predict the recurrence or metastases of meningioma and histological grading, according to WHO criteria, is the most important predictor of malignancy. A rare case of a woman with a relapse of intracranial meningioma in the right frontal lobe who subsequently developed simultaneous bone and intrapulmonary metastases is reported. According to these sites of metastases, it is suggested that in patients with a history of relapsed meningioma, a total body CT scan should be performed in order to investigate other possible sites of disease.

AB - Fifteen percent of intracranial tumors are represented by meningiomas. Meningioma is usually a benign neoplasm; malignant histology is rare and represents about 2-10% with a 43% incidence of metastasis. The most frequent site of metastasis is the lung and rare are other sites. There are no definitive criteria to predict the recurrence or metastases of meningioma and histological grading, according to WHO criteria, is the most important predictor of malignancy. A rare case of a woman with a relapse of intracranial meningioma in the right frontal lobe who subsequently developed simultaneous bone and intrapulmonary metastases is reported. According to these sites of metastases, it is suggested that in patients with a history of relapsed meningioma, a total body CT scan should be performed in order to investigate other possible sites of disease.

KW - Lung and bone metastases

KW - Malignant meningioma

UR - http://www.scopus.com/inward/record.url?scp=33750715401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750715401&partnerID=8YFLogxK

M3 - Article

C2 - 17094409

AN - SCOPUS:33750715401

VL - 26

SP - 3835

EP - 3837

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -